| Pharmaceutical active ingredients: |
| MetamizolePramiverine Hydrochloride |
| Available forms, composition and doses of Syntaverin: |
| N / A |
| Syntaverin medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02BB52 - Metamizole Sodium, combinations excluding psycholeptics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Merck |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Syntac-D | Domperidone; Ranitidine | Synokem Pharmaceuticals |
| Syntam | Piracetam | Synmosa Biopharma Corporation; Zyfas Medical |
| Syntapon | Sodium Lauryl Sulfate | Unidentified Pharmaceutical Company |
| Syntaris | Flunisolide | Roche; Dermapharm; IVAX; Recordati |
| Syntarpen | Cloxacillin | Unidentified Pharmaceutical Company |
| Syntedril | Diphenhydramine | Unidentified Pharmaceutical Company |
| Syntemax | Dexamethasone Sodium Phosphate; Neomycin Sulfate; Polymyxin B Sulfate | Pascual Laboratories; Optaderm Pharma |
| Synterin | Rolitetracycline | Unidentified Pharmaceutical Company |
| Syntermycin | Oxytetracycline Hydrochloride | Synco; Singapore Pharmaceutical |
| Syntesor | Hydrocortisone Sodium Succinate | EuroHealthcare |